Aβ-binding small molecules
View Patent ↗In one aspect, the present invention provides for compounds and labeled compounds of Formula I, and pharmaceutical compositions thereof. In another aspect, the present invention provides for methods of using compounds or labeled compounds of Formula I for various therapeutic and imaging purposes, including, but not limited to, treating Alzheimer's disease in patient and imaging Aβ peptide aggregates in a patient.
1. A compound of Formula I:
or a pharmaceutically acceptable salt thereof, wherein in Formula I:
L is C 1-6 alkylene;
X is phenyl substituted with fluorine, bromine or iodine;
Ar is phenyl substituted at the 4-position with one substituent selected from the group consisting of perfluoro(C 1 -C 4 )alkoxy and —OR c ;
wherein R c is C 1-4 alkyl;
R 1 is a member selected from the group consisting of hydrogen, C 1-6 alkyl and C 1-6 haloalkyl;
R 2 is a member selected from the group consisting of hydrogen, halogen, C 1-6 alkoxy, C 1-6 alkylamino, C 1-6 dialkylamino, C 1-6 alkyl and C 1-6 haloalkyl;
R 3a and R 3b are each a member independently selected from the group consisting of hydrogen, C 1-6 alkyl, C 1-6 haloalkyl, and C 1-6 alkoxy, and wherein R 3a and R 3b and the nitrogen atom to which each is attached are optionally combined to form a 5- to 6-membered ring; and
the subscript m is 1.
2. The compound of claim 1 , wherein L is selected from the group consisting of —CH 2 —, —CH 2 CH 2 —, —CH 2 CH 2 CH 2 —, and —CH 2 CH 2 CH 2 CH 2 —.
3. The compound of claim 1 , wherein L is selected from the group consisting of —CH 2 —, —CH 2 CH 2 —, and —CH 2 CH 2 CH 2 —.
4. The compound of claim 1 , wherein Ar is selected from the group consisting of:
5. The compound of claim 1 , wherein said compound is of Formula Ia
6. The compound of claim 1 , wherein said compound is selected from the group consisting of
3-(3-iodo-benzyl)-2-(4-methoxy-phenylamino)-8-methyl-6-oxo-3,6-dihydrochromeno [6,7-d]imidazole-7-carboxylic acid amide;
3-(3-bromobenzyl)-2-(4-methoxyphenylamino)-8-methyl-6-oxo-3,6-dihydrochromeno [7,6-d]imidazole-7-carboxylic acid amide;
3-(3-fluorobenzyl)-2-(4-methoxyphenylamino)-8-methyl-6-oxo-3,6-dihydrochromeno [7,6-d]imidazole-7-carboxylic acid amide;
3-(4-bromobenzyl)-2-(4-methoxyphenylamino)-8-methyl-6-oxo-3,6-dihydrochromeno [7,6-d]imidazole-7-carboxylic acid amide;
3-(4-iodobenzyl)-2-(4-methoxyphenylamino)-8-methyl-6-oxo-3,6-dihydrochromeno [7,6-d]imidazole-7-carboxylic acid amide;
3-(4-bromophenethyl)-2-(4-methoxyphenylamino)-8-methyl-6-oxo-3,6-dihydrochromeno [7,6-d]imidazole-7-carboxylic acid amide;
3-(3-bromobenzyl)-8-methyl-6-oxo-2-(4-(trifluoromethoxy)phenylamino)-3,6-dihydrochromeno [7,6-d]imidazole-7-carboxylic acid amide;
3-(3-iodobenzyl)-8-methyl-6-oxo-2-(4-(trifluoromethoxy)phenylamino)-3,6-dihydrochromeno [7,6-d]imidazole-7-carboxylic acid amide; and
3-(4-bromobenzyl)-8-methyl-6-oxo-2-(4-(trifluoromethoxy)phenylamino)-3,6-dihydrochromeno [7,6-d]imidazole-7-carboxylic acid amide.
7. The compound of claim 1 , wherein said compound is selected from the group consisting of:
8. The compound of claim 1 , wherein said compound is:
9. The compound of claim 1 , wherein said compound is selected from the group consisting of:
10. The compound of claim 1 , wherein said compound is: